EverImmune
Development of live biotherapeutic products in the field of microbiota oncology.
EverImmune has raised €8.7M across 2 funding rounds from 2 investors, most recently a round in Sep 2023. Based in Villejuif, France; active in Healthtech. Data as of 28 Oct 2026.
Villejuif, Francewww.everimmune.com ↗
Total raised
€8.7M
€8,740,296
Funding rounds
2
Investors
2
distinct backers
Active since
2021-11
latest 2023-09
Funding by year
EUR raised per yearEverImmune — funding by year — interactive chart.
Data table
| EverImmune — funding by year | |
|---|---|
| 2021 | €5.3M |
| 2023 | €3.5M |
Signals
High confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-19 | Other | €3.5M | Bpifrance | View deal → |
| 2021-11-30 | Series A | €5.3M | Private Investors | View deal → |
Investors
2BpifrancePrivate Investors
Related news
- EverImmune Raises €5M in Series A Fundingfinsmes.com · 2021-12
- tech.eu
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData